Riskpilot← Back to searchSign inGet full accessBODY ANALYSE AS
ASActiveOrg 988897493Kvernslåttvegen 17, 5237 RådalAndre helsetjenester · NACE 86909Est. 20051 employeesbodyanalyse.no
Revenue 2023
NOK 1,6M
-38% vs 2022
EBITDA margin
20.8%
-71% vs 2022
Equity ratio
62.7%
Financial strength
Net profit 2023
NOK 154K
-81% vs 2022
| Revenue | NOK 1,6M | -38% |
| EBITDA | NOK 343K | -71% |
| Net profit | NOK 154K | -81% |
| Total assets | NOK 803K | -63% |
| Equity | NOK 504K | +44% |
| Employees | 1 | — |
Legal name
BODY ANALYSE AS
Org number
988897493
Legal form
Aksjeselskap
NACE code
86909 · Andre helsetjenester
Founded
12. november 2005
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Selskapets formål er kjøp og salg av varer og tjenester rettet mot helse, trening og velvære, samt hva som står naturlig i forbindelse herved, herunder deltakelse i andre selskaper.
Address
Kvernslåttvegen 17, 5237 Rådal
Website
bodyanalyse.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 3 170 | 2 269 | 2 239 | 2 662 | 1 647 |
| Staff expenses | −833 | −354 | −288 | −755 | −905 |
| EBITDA | 1 173 | 796 | 1 155 | 1 177 | 343 |
| Depreciation & amort. | −97 | −172 | −159 | −160 | −172 |
| EBIT | 1 076 | 624 | 996 | 1 016 | 171 |
| Net financials | 10 | 2 | 2 | 4 | 27 |
| Profit before tax | 1 086 | 626 | 998 | 1 021 | 198 |
| Tax | 241 | 138 | 220 | 225 | 44 |
| Net profit | 845 | 487 | 778 | 796 | 154 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 2 081 | 2 251 | 2 601 | 2 146 | 803 |
| Equity | 988 | 1 476 | 754 | 350 | 504 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 093 | 775 | 1 847 | 1 796 | 299 |
| Total debt | 1 093 | 775 | 1 847 | 1 796 | 299 |
EBITDA margin
20.8%
This company
15.8%
Market median
+32% vs market
20192023
Equity ratio
62.7%
This company
38.2%
Market median
+64% vs market
20192023
Return on equity
30.6%
This company
18.4%
Market median
+66% vs market
20192023
Net profit margin
9.4%
This company
8.1%
Market median
+16% vs market
20192023
Asset turnover
2.05×
This company
1.12×
Market median
+83% vs market
20192023
Debt / equity
0.59×
This company
0.62×
Market median
+5% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AS Deputy Member | Deputy Member | 2012 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2012 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lysets Kriger As
BODY ANALYSE AS Board members of BODY ANALYSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Andreas Salomonsen Bjarto | Deputy Member | 0 companies |
| Dag Arne Bjarto | Chairman | 0 companies |